VVUS News 3.86 10/01/2014 06:14:43 Vivus Inc (VVUS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vivus Inc (VVUS) 3.86 $VVUS

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 5:25PM CDT
VIVUS, Inc. (VVUS) and Auxilium Pharmaceuticals, Inc. (AUXL) announced that the FDA has approved Stendra's supplemental new drug application.

Nasdaq stocks posting largest volume increases
AP - Fri Sep 19, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Most active Nasdaq-traded stocks
AP - Fri Sep 19, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Oracle and Concur are big market movers
AP - Fri Sep 19, 3:40PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:

3 Biotechs Investors Should Watch
Brian Orelli, The Motley Fool - Motley Fool - Fri Sep 19, 12:49PM CDT
In the heathcare version of "Where the Money Is", guest Brian Orelli joins regulars Michael Douglass and David Williamson to discuss the state of the healthcare sector. In M&A news, Endo International has made an unsolicited bid to acquire ...

VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 8:32AM CDT
VIVUS Inc. (VVUS) was a big mover last session, as the company saw its shares rise more than 12% on the day.

Critical Alerts For FireEye, VIVUS, Ebix, 58.com and Walter Energy Released By InvestorsObserver
PR Newswire - Fri Sep 19, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for FEYE, VVUS, EBIX, WUBA and WLT.

Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent
PR Newswire - Fri Sep 19, 7:15AM CDT
BioTech News Coverage: Progress made as biotech companies release latest developments, patents and results of studies and trials. Companies in focus are: GenSpera Inc. (OTC: GNSZ), Eli Lilly and Company (NYSE: LLY), Gilead Sciences Inc. (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG) and Arena Pharmaceuticals Inc. (NASDAQ: ARNA)

Market Maker Surveillance Report. MSON, VVUS, CNQR, PIP, CREG, CRRS, Winning Stocks With Lowest Price Friction For Thursday, September 18th 2014
M2 - Fri Sep 19, 4:02AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4944 companies with "abnormal" market making, 2520 companies with positive Friction Factors and 2350 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Misonix Inc (NASDAQ:MSON), Vivus Inc (NASDAQ:VVUS), Concur Technologies Inc (NASDAQ:CNQR), PharmAthene Inc (NYSE IP), China Recycling Energy Corp (NASDAQ:CREG), Corporate Resource Services Inc (OTC:CRRS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Vivus Set to Possibly Pullback After Yesterday's Rally of 12.37%
Comtex SmarTrend(R) - Thu Sep 18, 4:16PM CDT
Vivus (NASDAQ:VVUS) traded in a range yesterday that spanned from a low of $4.21 to a high of $4.82. Yesterday, the shares gained 12.4%, which took the trading range above the 3-day high of $4.07 on volume of 34.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why VIVUS, Inc. Is Today's Best Biotech Stock
Sean Williams, The Motley Fool - Motley Fool - Thu Sep 18, 12:26PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of VIVUS , a biopharmaceutical company...

FDA OKs faster-acting label for ED drug Stendra
By The Associated Press - AP - Thu Sep 18, 11:21AM CDT
Federal regulators have approved a new label for Vivus' impotence drug, stating that it becomes effective in half the time that the previous label had stated.

Hot Stock: Vivus, Shares Gain 10.8% (VVUS)
Comtex SmarTrend(R) - Thu Sep 18, 10:08AM CDT
Vivus (NASDAQ:VVUS) is one of today's best performing low-priced stocks, up 10.8% to $4.30 on 10.1x average daily volume. Vivus has traded 14.0 million shares thus far today, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (10.8% to the Dow's 0.5%) and outperformed the S&P 500 (10.8% to the S&P's 0.4%) during today's trading.

Why VIVUS (VVUS) Stock Is Up Today
at The Street - Thu Sep 18, 9:17AM CDT
Shares of VIVUS (VVUS) were up in morning trading Thursday after the FDA approved the company's erectile dysfunction drug Stendra.

VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile Dysfunction Treatment Approved to Be Taken Approximately 15 Minutes Before Sexual Activity
Marketwire - Thu Sep 18, 5:01AM CDT
VIVUS, Inc. (NASDAQ: VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for STENDRA® (avanafil). STENDRA is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.

VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity
PR Newswire - Thu Sep 18, 5:00AM CDT
VIVUS, Inc. (Nasdaq: VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for STENDRA® (avanafil). STENDRA is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.

5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Wed Sep 17, 9:51AM CDT
Arena Pharmaceuticals held a press conference in conjunction with its second-quarter earnings to let investors know what's happening with its obesity drug Belviq and the rest of its pipeline. Below, you'll find five quotes from the call that...

Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy
at The Street - Tue Sep 16, 8:48AM CDT
Patients lost 12% of their body weight following 12 weeks of treatment with Arena's Belviq plus phentermine.

2 New Diet Drugs Coming Soon?
George Budwell, The Motley Fool - Motley Fool - Sat Sep 13, 1:05PM CDT
America's love of "supersized" everything has helped fuel an out-of-control obesity problem that is having dire consequences on human health and the economy. For instance, the CDC estimates that the annual medical cost of obesity in the U.S., as of...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 106

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 156

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 79

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 56

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 89

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 221

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 16

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 85

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 88

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 85

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading

Top 5 Most Recently Viewed Articles

Disney Steers Focus Towards Asia's Streaming Landscape Success

Updated Category News Views 192

Disney Enters the Competitive Asian Streaming Market Walt Disney Co (NYSE: DIS) is strategically positioning itself to dominate in the vibrant Asian streaming market. The company's latest initiative involves a significant investment in original Japanese anime, alongside the expansion of its Korean superhero franchise. With this bold move, Disney aims to establish a strong...

Continue Reading
MSSA and GSMA Unite to Expand Mobile Satellite Services

Updated Category News Views 81

Strategic Alliance of MSSA and GSMA The Mobile Satellite Services Association (MSSA) has announced an exciting new partnership with the GSMA, a leading global organization dedicated to mobile operators and the broader mobile ecosystem. This synergy aims to elevate mobile technology to new heights and transform the landscape of mobile satellite communications. Advancing...

Continue Reading
Celebrating Pioneers: 2025 XCEL Summit for Men Highlights Heroes

Updated Category News Views 259

Honoring Leadership at the 2025 XCEL Summit for Men Black Enterprise is excited to showcase the remarkable individuals receiving the prestigious XCEL Awards at the much-anticipated XCEL Summit for Men. This year's celebration promises to be a hallmark event, scheduled for mid-October at the Hyatt Regency Grand Cypress in Orlando. Attendees can expect a magnificent...

Continue Reading
Innovative Trial Launches to Combat Pediatric Leukemia Worldwide

Updated Category News Views 259

Revolutionizing Pediatric Leukemia Treatment The Leukemia & Lymphoma Society (LLS) has embarked on an extraordinary journey with the launch of the PedAL (Pediatric Acute Leukemia) Master Clinical Trial, a trailblazing effort that marks the world's first-ever global trial focused on menin inhibitors for treating pediatric leukemia. This initiative is part of LLS's broader...

Continue Reading
Aflac Partners with Workday to Enhance Employee Benefits Experience

Updated Category News Views 196

Aflac's Collaboration with Workday for Enhanced Wellness Solutions Aflac, a prominent provider of supplemental insurance in the U.S., has entered into a partnership with Workday Wellness aimed at revolutionizing employee benefit offerings. This strategic relationship empowers employers to provide a more personalized experience for their workforce, ultimately aimed at...

Continue Reading